Search

Learn how Kéara was able to maintain her quality of life after treatment for triple negative breast cancer.

… Monday, April 4, 2022 When Kéara Richardson was diagnosed with triple-negative breast cancer at just 37, she feared her life would never be the same again. But Memorial Sloan Kettering Cancer Center (MSK) offered her an innovative treatment that puts chemotherapy before breast cancer surgery . This approach

Scientists are learning how tumors develop resistance to drugs — and what can be done about it.

… Thursday, July 27, 2017 Summary Drugs targeting a particular mutation in cancer cells can be an effective form of therapy. But the beneficial effects are often short-lived as tumors quickly develop resistance. New research is casting light on how this resistance evolves and what treatment approaches

Meet Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, who is deeply satisfied with her work and delighted with her family, which will soon expand — Vikki is expecting her second child in August with her fiancée, Shauna.

… Monday, June 28, 2021 Within two minutes of meeting Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, you recognize that you are in the presence of a powerful, positive force to be reckoned with, someone who is happily and energetically creating

Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity of the α6ß4 subunit of this integrin on vascular cells, researchers found they could slow the growth of tumors.

… Tuesday, February 8, 2005 Summary Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.

… Tuesday, July 30, 2019 Summary Learn why our specialists are among the best in the world at treating cervical cancer , uterine (endometrial) cancer , and ovarian cancer . In its 2019–2020 listing of the nation’s best hospitals, U.S. News & World Report  ranks Memorial Sloan Kettering as number one for

Combining checkpoint blockade with engineered T cells may lead to longer-lasting results in patients with breast cancer, lung cancer, and other solid tumors.

… Thursday, July 28, 2016 Summary Memorial Sloan Kettering is a leader in developing immunotherapies to treat cancer. Now researchers say combining two different immune approaches may better treat solid tumors. The immunotherapy treatment known as CAR T cell therapy , while still experimental, is showing

Cancers linked to HPV are on the rise. But only a little over half of all adolescents in the U.S. got the full series of vaccinations. In this Q&A, Chrisann Kyi talks about why it's so important for young people to get vaccinated.

… Thursday, September 27, 2018 Summary HPV-associated cancers are on the rise, but only about half of all adolescents in the United States have received the full series of shots. In this Q & A, Chrisann Kyi talks about why it’s so important for young people to get vaccinated. Update: On October 5, 2018

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.

… Friday, December 23, 2022 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.

… Tuesday, June 1, 2010 Summary A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness. It has long been known that circulating tumor cells (CTCs) — cells that have broken away from a

If you think women are the only people who get cancers caused by the human papillomavirus (HPV), think again. These cancers are on the rise in men.

… Thursday, June 10, 2021 Rich Delgrosso found the lump while shaving. It was on the left side of his neck and it seemed to grow bigger by the day. He made an appointment with his ear, nose, and throat doctor. “He said the odds were 50/50 that it was an infection,” recalls the 56-year-old father of two